The oral protein-kinase C β inhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines. - Neri, Antonino; Marmiroli, Sandra; Tassone, Pierfrancesco; Lombardi, Luigia; Nobili, Lucia; Verdelli, Donata; Civallero, Monica; Cosenza, Maria; Bertacchini, Jessika; Federico, Massimo; De Pol, Anto; Deliliers, Giorgio Lambertenghi; et al. (Leukemia & Lymphoma, 2008)